Astrazeneca LP v. Sigmapharm Laboratories, LLC

Court

District Court, E.D. Pennsylvania (E.D. Pa.)
Official Court Website →

Assigned judge

Gerald A. Mchugh · 900 cases in index

Docket number

2:15-cv-05948

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal question

Date filed

11/02/2015

Date terminated

12/16/2015

1,364 Patent cases in this court are indexed here.

Parties

• plaintiff · Astrazeneca LP Pharmaceuticals & Biotechnology · 10349 cases
• defendant · Sigmapharm Laboratories, LLC · 11 cases

Part of a Larger Litigation Pattern

This is one of 12 Patent cases in our index naming Sigmapharm Laboratories, LLC — a possible mass-tort or coordinated-litigation cluster.

• Bayer Intellectual Property GmbH v. Sigmapharm Laboratories, LLC
  District Court, D. DelawareFiled 05/26/2017
• Bristol-Myers Squibb Company v. Sigmapharm Laboratories, LLC
  District Court, D. DelawareFiled 04/10/2017
• Gilead Sciences, Inc v. Sigmapharm Laboratories, LLC
  District Court, E.D. PennsylvaniaFiled 07/16/2015
• Gilead Sciences, Inc v. Sigmapharm Laboratories, LLC
  District Court, D. New JerseyFiled 06/30/2015
• Forest Laboratories LLC v. Sigmapharm Laboratories LLC
  District Court, D. DelawareFiled 09/03/2014
• Gilead Sciences, Inc v. Sigmapharm Laboratories, LLC
  District Court, E.D. PennsylvaniaFiled 09/29/2010

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is Astrazeneca LP v. Sigmapharm Laboratories, LLC?

Astrazeneca LP v. Sigmapharm Laboratories, LLC is a federal patent lawsuit filed on 11/02/2015 in the District Court, E.D. Pennsylvania. The case was terminated on 12/16/2015. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, E.D. Pennsylvania, docket number 2:15-cv-05948.

When was the case filed?

Astrazeneca LP v. Sigmapharm Laboratories, LLC was filed on 11/02/2015. It was terminated on 12/16/2015.